Join Our Community

Thanks to the hard work of advocates in the kidney cancer community, Congress has allocated $50 million in federal funding for research in 2021. Twice a year KidneyCAN organizes calls and visits to congress to speak about the need for kidney cancer research. We need your help to continue the progress in funding kidney cancer research.

FOR PATIENTS

Whether you are a patient, caregiver, family member or friend, there is no greater way to impact our lawmakers than to share how kidney cancer has impacted your life. The passion you have to pursue advanced treatments or cure will translate to action!  Patients and their families are at the heart of the grassroots army that has taken earmarked federal dollars for research from $0 to $50 million a year.

You and your loved ones can be a part of this army! There is strength and empowerment in “giving back”.

WHY ADVOCATE?

GET INVOLVED

SPEAK UP FOR FUNDING

KidneyCAN President Bryan Lewis and Dr. Andrew Smith of University of Alabama at Birmingham describe the importance of advocating for kidney cancer research funding and the impact it has on patient treatment.

SPEAK UP FOR FUNDING

KidneyCAN President Bryan Lewis and Dr. Andrew Smith of University of Alabama at Birmingham describe the importance of advocating for kidney cancer research funding and the impact it has on patient treatment.

The Need for Advocacy & Involvement

DISTRICT DAYS 2021

RAISING AWARENESS

WAYS TO GIVE

RESEARCH OPPORTUNITIES

KCRS INFO & PRESENTATIONS

FOR RESEARCHERS

You might be here on the KidneyCAN site learning more about the DoD CDMRP Kidney Cancer Research Awards.

Did you know you can impact the amount of research dollars ultimately allocated? Your firsthand account of the cost and value of cancer research provides a unique and needed perspective when we talk to congressional representatives.

Please take the opportunity and support these advocacy visits and be part of the powerful, united voice we need to make a difference! We need basic science and translational researchers to be part of this grassroots army.

 

For Patients

Advocacy

Research

Join Our Grassroots Army

We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

For this installment of #KidneyCANDID, Dr. Sumanta Pal of City of Hope shares two things patients can do as they prepare for their #kidneycancer appointments.
▶️ Questions & Support: What to Bring to Your Kidney Cancer Oncology Appointment
Watch here: https://youtu.be/eSHbG7OeYHg
Have a topic you'd like us to cover in another episode of #KidneyCANDID? Comment below or email us at info@kidneycan.org!

For this installment of #KidneyCANDID, Dr. Sumanta Pal of City of Hope shares two things patients can do as they prepare for their #kidneycancer appointments.

▶️ Questions & Support: What to Bring to Your Kidney Cancer Oncology Appointment

Watch here: https://youtu.be/eSHbG7OeYHg

Have a topic you'd like us to cover in another episode of #KidneyCANDID? Comment below or email us at [email protected]!
...

7 0
It's not too late to join us for the next Town Hall event in our series! Learn about shared decision-making and your immunotherapy choices from leading oncologists. 
Register now: https://bit.ly/ImmunotherapyTownHall
#kidneycan #immunotherapy #townhall #livingwithcancer #cancerlife #kidneycancer #patienteducation

It's not too late to join us for the next Town Hall event in our series! Learn about shared decision-making and your immunotherapy choices from leading oncologists.

Register now: https://bit.ly/ImmunotherapyTownHall

#kidneycan #immunotherapy #townhall #livingwithcancer #cancerlife #kidneycancer #patienteducation
...

7 0
It's not too late to register for our next Town Hall event! Learn about immunotherapy choices for #kidneycancer treatment from leading oncologists. We'll have Dr. Naomi Haas from Penn Medicine, Dr. Hans Hammers from UTSW, and Dr. Monty Pal from City of Hope. 
📅 Tues, April 26
🕔 5:00 PM EDT
💻 Free Webinar via Zoom
Register now! https://bit.ly/ImmunotherapyTownHall
#kidneycan #livingwithcancer #cancerlife #patienteducation #empoweredpatient #shareddecisionmaking

It's not too late to register for our next Town Hall event! Learn about immunotherapy choices for #kidneycancer treatment from leading oncologists. We'll have Dr. Naomi Haas from Penn Medicine, Dr. Hans Hammers from UTSW, and Dr. Monty Pal from City of Hope.

📅 Tues, April 26
🕔 5:00 PM EDT
💻 Free Webinar via Zoom

Register now! https://bit.ly/ImmunotherapyTownHall

#kidneycan #livingwithcancer #cancerlife #patienteducation #empoweredpatient #shareddecisionmaking
...

7 0
Reminder! Our next patient education town hall will explore immunotherapy options for #kidneycancer patients. 
📅  April 26th
🕔 5:00 pm ET
💻 via Zoom webinar
Register here: https://bit.ly/ImmunotherapyTownHall
Featuring Drs. Naomi Haas of UPenn, Hans Hammers of UTSW, and Monty Pal of City of Hope. Join us to hear this panel of leading expert oncologists discuss how they share the immunotherapy decision-making process with their patients.

Reminder! Our next patient education town hall will explore immunotherapy options for #kidneycancer patients.

📅 April 26th
🕔 5:00 pm ET
💻 via Zoom webinar

Register here: https://bit.ly/ImmunotherapyTownHall

Featuring Drs. Naomi Haas of UPenn, Hans Hammers of UTSW, and Monty Pal of City of Hope. Join us to hear this panel of leading expert oncologists discuss how they share the immunotherapy decision-making process with their patients.
...

7 0
Researchers! KidneyCAN is accepting abstracts for the 2022 Kidney Cancer Research Summit on October 6-7 in Philadelphia, PA. 
Don't miss the opportunity to be part of this incredible meeting for #kidneycancer specialists. 
Abstract submission guidelines and full details here: http://bit.ly/KCRS22Abstracts
#kidneycancerresearch #cancerresearch #kcsm

Researchers! KidneyCAN is accepting abstracts for the 2022 Kidney Cancer Research Summit on October 6-7 in Philadelphia, PA.

Don't miss the opportunity to be part of this incredible meeting for #kidneycancer specialists.

Abstract submission guidelines and full details here: http://bit.ly/KCRS22Abstracts

#kidneycancerresearch #cancerresearch #kcsm
...

6 0
Another educational opportunity for #KidneyCancer patients! 
Learn from some of the nation's top doctors at Yale Cancer Center. Tomorrow night (Thursday) at 7:00 PM ET. 
Register: https://zoom.us/webinar/register/WN_1uI0atogTR2VKcFC_W78Fg

Another educational opportunity for #KidneyCancer patients!
Learn from some of the nation's top doctors at Yale Cancer Center. Tomorrow night (Thursday) at 7:00 PM ET.

Register: https://zoom.us/webinar/register/WN_1uI0atogTR2VKcFC_W78Fg
...

8 0
Hear the latest in kidney cancer care, emerging therapies and general wellness from Dr. Thomas Hutson DO, Pharm.D., FACP of Texas Oncology and a panel of experts at @curetoday's Educated Patient® Kidney Cancer Summit on Saturday, April 9th . 
Connect with the kidney cancer community and empower your own journey! 
Learn more and reserve your virtual seat: 
http://ow.ly/weVJ50Ivtjy 
#educatedpatient #kidneycancer

Hear the latest in kidney cancer care, emerging therapies and general wellness from Dr. Thomas Hutson DO, Pharm.D., FACP of Texas Oncology and a panel of experts at @curetoday's Educated Patient® Kidney Cancer Summit on Saturday, April 9th .

Connect with the kidney cancer community and empower your own journey!

Learn more and reserve your virtual seat:
http://ow.ly/weVJ50Ivtjy

#educatedpatient #kidneycancer
...

11 0
We continue to honor the caregivers in our community during #KidneyCancerAwareness month. Tracy shares her insightful perspective along with the decisions she and her wife Julie had to make when facing a diagnosis.
Read more:
https://kidneycan.org/tracys-story-a-caregivers-perspective/
#kidneycancer #caregiving #cancerlife #livingwithcancer #caregiving #KCAM

We continue to honor the caregivers in our community during #KidneyCancerAwareness month. Tracy shares her insightful perspective along with the decisions she and her wife Julie had to make when facing a diagnosis.

Read more:
https://kidneycan.org/tracys-story-a-caregivers-perspective/

#kidneycancer #caregiving #cancerlife #livingwithcancer #caregiving #KCAM
...

9 0
Ralph Knapp, your community loves and remembers you. 
Thank you all for your messages of support. 
🧡💚✨

Ralph Knapp, your community loves and remembers you.

Thank you all for your messages of support.

🧡💚✨
...

34 1

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Let’s Get Loud: Spring 2022 Advocacy Days

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING A CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

IKCC Report: Retention in Clinical Trials

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials. Clinical trials are the key to...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...